News sentiment analysis powered by sentiment-insight.com
Pfizer Inc. (NYSE:PFE) Q3 2023 Earnings Call Transcript
Pfizer Inc. (NYSE:PFE) Q3 2023 Earnings Call Transcript October 31, 2023. Francesca DeMartino, Chief Investor Relations Officer, will lead the way. Today's call is being recorded.
Apple earnings, Fed decision, and Jobs data highlight big week: Yahoo Finance Live Investors are bracing for a massive week on Wall Street. Pfizer (PFE), Caterpillar (CAT), Starbucks (SBUX), and Roku (ROKU) are among the top names reporting. The Federal Reserve will announce its latest interest rate decision on Wednesday afternoon. Yahoo Finance trending tickers include: McDonald’s (MCD), SoFi (SOFI), and JPMorgan (JPM)
13 Best Blue Chip Stocks Under $100 Some analysts were expecting the Fed to start rate cuts in 2024 but the latest jobs report might have dampened those hopes. Pfizer Inc. (NYSE:PFE) is priced well under $100 and hedge funds simply love this name, thanks to the company’s diverse pipeline, growth catalysts and dividends. Micron Technology (NASDAQ:MU) shares have gained about 37% year to date.
Big Pharma Could Transform Into BioTech Pharma Mainz Biomed’s flagship product is the first DNA-based screening test for colorectal cancer in Europe. In Romania alone, the potential market for ColoAlert consists of 9.2 million individuals who are aged over 40. Pfizer Inc (NYSE: PFE) invested $25 million in exchange for a minority stake in Caribou Biosciences (NASDAQ: CRBU)
Coinbase CEO Brian Armstrong exclusive, Meta’s VR announcements: Yahoo Finance Live Coinbase (COIN) CEO Brian Armstrong calls out what he sees as “harassment” from the Securities and Exchange Commission. Meta (META) is unveiling its latest virtual reality products. Other trending tickers on Yahoo Finance include NextEra Energy (NEE), Palantir (PLTR), and Pfizer (PFE)
Down 25% In A Year Will Pfizer Stock Rebound To Its Pre-Inflation Shock Level? Pfizer stock (NYSE: PFE) currently trades at $37 per share, aligning with the level seen in March 2021. Pfizer benefited from strong demand for its Covid-19 products in 2021 and 2022, but that trend has now reversed.
Undervalued Biotech Gems: Two Stocks Combining Dividends with Healthy Returns Pfizer Inc (PFE) has experienced a decline of about 31% year-to-date. Pfizer is gearing up to pay its 338th quarterly dividend in Q2 2023. The biotech sector is renowned for its volatile nature.
Pfizer: Q2 Earnings Snapshot Pfizer Inc. (PFE) on Tuesday reported second-quarter net income of $2.33 billion. Earnings, adjusted for non-recurring costs, came to 67 cents per share. The results surpassed Wall Street expectations.
Pfizer (NYSE:PFE) Has Affirmed Its Dividend Of $0.41 The board of Pfizer Inc. (NYSE:PFE) has announced that it will pay a dividend on the 5th of September, with investors receiving $0.41 per share. This makes the dividend yield 4.6%, which will augment investor returns quite nicely. Pfizer's Payment Has Solid Earnings Coverage.
Apple Loses Appeal Over 4G Patent Infringement In London Court, AI Can Drive TSMC's Revenue Rebound, Alibaba Conducts Strategic Review of Youku and Tudou Amidst Rivalry: Today's Top Stories Nikola Corp (OTC: NKLA) stock is trading lower after reports indicated its plans to liquidate the assets of battery maker Romeo Power. Samsung Biologics and Pfizer Inc (NYSE: PFE) have signed two agreements for the long-term manufacturing of Pfizer's multiproduct biosimilar portfolio. Warren Buffett-backed Chinese EV giant BYD plans to start operations in three factories simultaneously in the Bahis's Camaçari industrial complex.
Pfizer Warns of Potential Pediatric Antibiotic Shortage Amid Surge in Syphilis Infections Pfizer Inc (NYSE: PFE) cautions about potential supply shortages for pediatric Bicillin L-A, an antibiotic for syphilis treatment. The company has prioritized the production of adult versions due to a surge in syphilis infections.
BioNTech's Ready-to-Use Single Dose Vaccine, the Perfect Counterattack to China's Rising XBB1.5 Cases BioNTech SE's CEO and co-founder Ugur Sahin told shareholders the company is working on COVID-19 vaccines targeting XBB.1.5 strains. Company is collaborating on the vaccine with Pfizer Inc (NYSE: PFE) in markets outside of greater China.
FDA Nods to Pfizer's Paxlovid for COVID-19: A Potential $8 Billion Lifesaver in 2023 FDA approves Pfizer's Paxlovid (nirmatrelvir and ritonavir) for mild-to-moderate COVID-19. FDA approval is based on safety and efficacy data from the EPIC clinical development program. PFE shares are down 2.18% at $37.79.
FDA Signals Support For Pfizer's Maternal RSV Shot Ahead Of Adcomm, Pfizer Raises $31B In Debt To Fund Seagen Deal Pfizer Inc (NYSE: PFE) plans to raise $31 billion from a debt offering to finance its proposed acquisition of Seagen Inc (NASDAQ: SGEN) for $43 billion. The debt offering, which would be in eight tranches, is expected to close on May 19.
Pfizer: Q1 Earnings Snapshot Pfizer Inc. (PFE) on Tuesday reported first-quarter profit of $5.54 billion. Earnings, adjusted for non-recurring costs, were $1.23 per share. The drugmaker posted revenue of $18.28 billion in the period.
Pfizer: Q1 Earnings Snapshot Pfizer Inc. (PFE) on Tuesday reported first-quarter profit of $5.54 billion. Earnings, adjusted for non-recurring costs, were $1.23 per share. The results surpassed Wall Street expectations.
Pfizer: Q1 Earnings Snapshot Pfizer Inc. (PFE) on Tuesday reported first-quarter profit of $5.54 billion. Earnings, adjusted for non-recurring costs, were $1.23 per share. The results surpassed Wall Street expectations.
Pfizer, Astellas' Xtandi Combo Therapy Cuts Risk Of Metastasis, Death In Prostate Cancer By 58% Astellas Pharma Inc (OTC: ALPMY) and Pfizer Inc (NYSE: PFE) announced detailed Phase 3 EMBARK trial data. The 1,068-patient trial hit the primary endpoint, metastasis-free survival (MFS)
Earnings This Week: When Do Apple, Ford and Uber Report Results? Norwegian Cruise Line (NCLH) and the medical-technology company Stryker (SYK) are among those due to report Monday. Tuesday: Marriott International (MAR), Pfizer (PFE) and Uber (UBER) first thing. Wednesday: CVS Health (CVS) and Kraft Heinz (KHC) in the morning; Zillow (Z) is due after the close.
These Analysts Boost Price Targets On Seagen Following Acquisition News - NewsBreak Seagen shares jumped 14.5% to close at $197.65 on Monday. Pfizer Inc (NYSE: PFE ) agreed to acquire Seagen Inc (NASDAQ: SGEN ) for $229 in cash per Seagen share.
Sign Up
